Home' Trinidad and Tobago Guardian : June 20th 2014 Contents A36
body & soul
Guardian www.guardian.co.tt Friday, June 20, 2014
NATIONAL HELICOPTER SERVICES LIMITED
National Helicopter Services Limited, a leading provider of helicopter transport
and related services to the energy and state sectors, is seeking to recruit a
suitably qualified professional to fill the following position:
DIRECTOR OF CORPORATE SERVICES
The Director of Corporate Services (DOCS) forms a critical part of the Executive Management Team and
has overall responsibility for the leadership of a diverse portfolio of functions including Human Resources,
Finance, Facilities Management, ICT and Procurement functions. The incumbent will ensure that all of
these services are offered to the highest standard and that the organization runs smoothly, efficiently and
economically. The DOCS leads, coaches, mentors and develops the senior staff of all departments that
report to the position.
Major Duties and Responsibilities:
Leads the ongoing development of a professional and achievement focused workforce and culture.
Designs and leads corporate strategic change initiatives across the organization.
Provides visible and effective leadership to the Corporate Services Group.
Leads and promotes a strong internal service culture, ensuring a service delivery approach that is
responsive to the operational and strategic needs of the Company.
Acts as Deputy Accountable officer, undertaking related duties in the absence of the General Manager.
Required Qualifications and Skills
Post Graduate degree in Accountancy, HR, Law or Procurement and Logistics.
A minimum of ten (10) years' experience in a Senior Management position in a similar capacity or
in the areas of Accounts, Human Resources, Legal Services, or Procurement and Logistics.
Good people skills with proven ability to manage support and motivate staff.
Demonstrable experience in providing strategic leadership and influencing and leading change
across an organization.
Sound practical knowledge of corporate services functions in general, and in depth expertise in one
or more corporate service functional area(s)
Demonstrable IT literacy and ability to use HR and financial software.
Have a high degree of integrity, tact, diplomacy and corporate spirit.
Detailed applications together with copies of all documentary evidence of Academic Qualifications, Training
and Experience and the names of two Referees should be emailed to email@example.com or sent to:
The Human Resource Manager
National Helicopter Ser vices Limited
P.O. Bag 685
No later than 21st June 2014
Unsuitable applications would not be acknowledged.
These drugs called statins, help to reduce LDL cholesterol and are considered an effective way to reduce
heart disease risk.
their heart health have paid close
attention to their personal stats, hop-
ing for low levels of "bad" LDL cho-
lesterol and high levels of "good" HDL
A pair of new studies published
Wednesday in the New England Journal
of Medicine offer some of the most
persuasive evidence yet that a third
indicator of heart health---a form of fat
called triglycerides, which circulate in
the bloodstream---may be just as impor-
tant in determining heart health.
A massive genetic study led by a
Boston cardiologist has identified a
subset of people who carry rare muta-
tions that cause them to have dramat-
ically lower levels of triglycerides in
their blood. Those people, in turn, were
40 per cent less likely to have heart
disease than people who didn t have
A European study published in tan-
dem, including more than 75,000 peo-
ple, confirmed that mutations in the
same gene decreased triglyceride levels
and the risk of heart disease to almost
exactly the same extent as the Boston
study. The findings suggest that sci-
entists should be looking for a way to
mimic what the body does in those
people with naturally low levels of
"Everyone s been looking for what
are the pathways---what are the key
ways that people get heart attacks
beyond LDL cholesterol," said Dr Sekar
Kathiresan, director of preventive car-
diology at Massachusetts General Hos-
pital and an associate member of the
Broad Institute who led the new study.
"For 20 to 30 years, people have been
thinking it s HDL, and trying to raise
HDL. This work suggests it s actually
the triglycerides that are important."
It s clear that lowering LDL choles-
terol, which is targeted by drugs called
statins, is an effective way to reduce
heart disease risk.
But over the years, it has not been
clear whether HDL and triglycerides
are simply indicators of heart health or
actual causes of heart disease. It has
been an open question whether low-
ering or raising their levels will actively
change people s health---in short, are
these markers a thermometer or a ther-
The results of the new studies
strongly confirm and extend a surpris-
ing insight first gained by using an older
form of genome analysis to study a
small population of Amish people. In
that 2008 study, published in the jour-
nal Science, researchers gave partici-
pants a fatty, 1,500-calorie milkshake
and then measured how their bodies
responded over time.
They found that about five per cent
of Amish people who carried a mutation
in the gene APOC3 did not have a char-
acteristic spike in triglyceride after the
milkshake. Researchers also found that
those effects seemed to span a lifetime
and, as a result, the arteries of those
with the mutation had not hardened
But because of the difficulty of gath-
ering long-term data and the challenges
of determining the cause of death
among people who did not necessarily
go to the hospital, the researchers could
never conclusively finish the story and
show that the genetic mutation defi-
nitely prevented heart disease.
"What s exciting about this is it takes
that to another place," said Toni Pollin,
an associate professor of medicine at
the University of Maryland School of
Medicine, who led the 2008 work. "Just
as you d expect from something that
prevents coronary artery buildup, there
is strong evidence that having [a gene
mutation] reduces the risk of having a
Kathiresan and colleagues benefited
from the revolution in genome tech-
nology, sequencing 18,666 genes in
each of 3,734 people in their search for
genes that appeared to be linked to
triglycerides. Rare mutations in the
APOC3 gene stood out.
Once they understood where to look,
they searched for four mutations in
that gene in more than 110,000 people.
They found that people with any one
of the mutations---about one in 150
people---were 40 per cent less likely to
have heart disease and had lower levels
The APOC3 gene creates a protein
that inhibits swift removal of triglyc-
erides from the bloodstream.
Researchers theorise that in people who
are fortunate to have the mutation, the
protein is greatly decreased, causing
triglycerides to stay low.
In an earlier study on HDL, the
Boston team found that genetic muta-
tions that cause people to have high
HDL cholesterol---the "good" form---
appeared to have no effect on heart
health. That result came around the
same time that several high-profile
clinical trials of HDL-raising drugs
failed, suggesting that HDL was less
important than widely thought.
Dr Frank Sacks, a professor of car-
diovascular disease prevention at the
Harvard School of Public Health, said
that while the new studies are impor-
tant, they do not signal that people
should forget about HDL.
For one thing, he said, HDL remains
an excellent predictor of heart health.
The exact mechanism for raising HDL
may be crucial to developing drugs that
are effective---meaning two drugs that
raise HDL through different means may
have very different results. The drugs
tried so far may not have raised it in
the right way.
At least one company, Isis Pharma-
ceuticals in California, has a drug in
development that lowers triglycerides
by targeting the APOC3 protein.
YOUR DAILY HEALTH
News and Advice
Study: Triglycerides play
key role in heart health
Links Archive June 19th 2014 June 21st 2014 Navigation Previous Page Next Page